AddLife, a Sweden-based company, which is primarily involved in the healthcare industry, completed the acquisition of Healthcare 21, a healthcare company, for $290m. The acquisition of HC21 is a strategic milestone and establishes AddLife in Ireland and the UK. The acquisition is in line with AddLife’s strategy of expanding in relevant niches in Europe. HC21 gives us access to a very attractive customer base in clinical segments in which we have a high level of expertise and a portfolio of proprietary brands. “I am very enthusiastic about this acquisition. HC21 gives us a solid point of entry and a critical mass in two of Europe’s most attractive Life Science markets. The similarities between our and HC21’s business are striking. We have similar ranges of products and services and both businesses are run based on a decentralised business model that offers value creation and distribution of products and services within selected niches,” Kristina Willgård, AddLife CEO.